Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Foundation stone laid...

    Foundation stone laid for Biological E. vaccine unit in SEZ

    Written by supriya kashyap kashyap Published On 2017-02-07T11:00:15+05:30  |  Updated On 7 Feb 2017 11:00 AM IST
    Foundation stone laid for Biological E. vaccine unit in SEZ

    Hyderabad : City-based vaccine manufacturer Biological E. Limited (BE) said it has laid the foundation stone for new facility in SEZ at Genome Valley in Kolthur village near here, with an initial investment outlay of Rs 300 crore.


    Telangana Minister for IT and Industries K T Rama Rao laid the foundation in the presence of Paul Stoffels, Worldwide Chairman, Pharmaceuticals, Johnson and Johnson (J&J), Mahima Datla, Managing Director of BE, Jayesh Ranjan, IT Secretary of Telangana and Soumya Swaminathan, Director General, Indian Council of Medical Research, a company statement said.


    "BE is planning an initial investment of up to Rs 300 crore in this new plant, which would help the existing vaccines plant to augment the production and manufacture new products that are in the pipeline. This investment is in line with and part of the already earmarked overall outlay of Rs 1000 crore in the Genome Valley across BE's vaccines and pharma businesses that are underway," Datla said.


    The construction of the new facility on about 29 acres of land would be completed by April 2018 and commercial production is expected to begin by December 2019, she said.


    Once the company's expansion initiatives in the Genome Valley are completed, an additional employment opportunity for around 1000 people would be generated, Datla added.

    Dr Soumya SwaminathanGenome ValleyIndian Council of Medical ResearchJayesh RanjanJohnson and JohnsonK T Rama RaoMahima Datlavaccine
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok